FOR IMMEDIATE RELEASE
January 4, 2023 Ann Arbor, MI
Genomenon, a genomic intelligence company, announced that it will be participating in BIO Partnering @JPM Week 2024, which takes place from January 8th to January 12th in San Francisco, California.
Details of the event are as follows:
Event: BIO Partnering @JPM Week
Date: January 8-12, 2024
Registration: https://www.bio.org/events/bio-partnering-jpm/registration
Genomenon executives will be available to conduct one-on-one meetings with registered pharmaceutical companies and investors. They are looking to raise awareness within cancer and genetic disease therapeutics regarding the hidden costs caused by a lack of access to comprehensive genomic information at every phase of a drug program. Schedule your meeting with the Genomenon’s leadership team by connecting with one of our team members through the BIO Partnering system.
Genomenon is a leading genomic intelligence company transforming patient care by uncovering the genomic drivers of genetic disease and cancer. By combining the power of AI built on the world’s premier genomic data set with genomic expertise, the company simplifies complex genetic data into actionable insights. Genomenon's integrated software, data, and services solutions empower clients with advanced patient diagnosis and precision medicine development.
BIO is the world’s largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the U.S. and in more than 30 other nations.
BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.
For more information, visit www.bio.org